I am part of the unit working within one of Vinnova´s priority areas, Sustainainable Precision Health. I work mainly with international collaboration, health data, biologics and antimicrobial resistance. Building on my experience from Uppsala University I am also part of the team for Sustainable mobility.

The need to achieve green sustainable and rechargeable batteries with the highest possible energy and power content, in addition to a long life, is of utmost importance to reach the goal of a fossil-free society. The long-term BATTERY 2030+ research initiative currently consist of a core group of 17 organisations from 7 countries reresenting the full value chain from discovery to manufacturing and recycling. Together the aim is to join forces to develop the next generation of ultra-performing, sustainable and safe batteries. BATTERY 2030+ is coordinated by Prof. Kristina Edström at Uppsala University. It is funded by the European Commission through a Coordination and Support Action. As Project Manager I am responsible for managing the tasks and goals set up by the consortium together with a team of four people and the members of the consortium.

Mainly worked with international research policy and funding with a focus on medicine and health. I was responsible for a number of European and international initiatives such as the 1+ Million Genomes initiative, International Consortium of Personalised Medicine (IC PerMed) that aim to strengthen research and facilitate implementation of personalised medicine into health care and the European joint programme for Rare Diseases that is part of the current work programme for Societal Challenge 1 in H2020. I was also involved in the evaluation of clinical research in Sweden supported by ALF-funding.

Working towards increasing the involvement and success of Swedish researchers within the area of European Research and Development. The Swedish Research Council are involved in many parts of the latest EU framework program Horizon 2020 such as within:Excellent Science; ERC, FET, Marie Sklodowska Curie and Research Infrastructure.Societal Challenges; SC1 Health and demographic change, SC6 Europe in a changing world - inclusive, innovative and reflective societies.

Employed at the Monitoring Unit with the responsibility to monitor strategic research efforts and handling research applications and processes within the area of Medicine and Health. A special focus on Research Information Infrastructures such as SweCRIS and SwePub.

I had a coordinating role with the responsibility to plan project activities, identify external partners and administer the collaboration as well as performing laboratory work. We worked on two drug projects against Alzeimers Disease (AD) and against ALS (Amyotrophic Lateral Sclerosis). The ALS project was in the discovery phase focusing on developing efficacy assays and the AD project was in optimization phase evaluating the safety profile and bio-distribution of the molecules. The aim was to prepare our molecules for first time in man studies. The company also developed a biomarker assay for AD diagnostics.In addition, my work involved administrative duties such as data handling/storage, data analysis using excel and biostatistic programs and summarizing data in reports and presentations. Laboratory work: Cell assay development using primary cells and embryonic stem cells, method development using an ELISA based set up, direct binding assay using SPR technology (Biacore), western blot and size exclusion chromatography.

Project Leader for an antibody project directed against a pain target. I had the responsibility to move the project from the validation phase to optimization phase. My work included planning to reach milestone decisions according to set up timelines, presenting to internal decision committees to receive required resources and of course to coordinate and execute the work within the team to reach the set up goals. The team was international with half of the group situated in Cambridge and other functionalities in Montreal and Mölndal. It required a great deal of planning and good follow up to make sure each team member knew what their task was and to confirm that all persons involved agreed on decisions made at the meeting. Senior Research Scientist with a focus on protein technologies such as protein purification, protein characterization and protein interaction analysis. Laboratory work: Immuno-assay development for protein quantification using ELISA and Gyros set ups. Interaction analysis using SPR technology (Biacore). Abeta-aggregation analysis using SEC and WB. Protein separation technologies for purification and fractionation. Peptide profiling using MALDI.

Senior Scientist working with the production of protein drugs. The commercial operations department worked with sponsored research which meant shorter projects with a tight costumer contact and a strong focus on a timely delivery. It was challenging to work that close with the customer but also very rewarding. I optimized protein purification processes including the viral removal steps. My work also involved analytical method development and analytical process support.

My focus was on protein engineering, both site directed mutagenesis and combinatorial mutagenesis strategies. In the first project the aim was to select for a lipase variant that would perform better in washing powder. The other projects was focused on isolating novel binding pairs that could be used for purification, detection and to create higher order structures.